Literature DB >> 12027585

Regulation of membrane type-matrix metalloproteinases.

Sonia Hernandez-Barrantes1, Margarida Bernardo, Marta Toth, Rafael Fridman.   

Abstract

Pericellular proteolysis is a hallmark of tumor cell metastasis. The membrane type (MT)-matrix metalloproteinases (MMPs) constitute a distinctive group of membrane-bound MMPs that are central mediators of surface proteolytic events that regulate tumor cell motility, metastasis and angiogenesis. As membrane-tethered proteases, the MT-MMPs exhibit unique regulatory mechanisms and interactions with metalloproteinase inhibitors and other relevant molecules. This review will focus on new emerging information on the mechanisms that regulate MT-MMP processing, activity and inhibition, and their significance for enzyme function in the tumor microenvironment. Copyright 2002 Elsevier Science Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12027585     DOI: 10.1006/scbi.2001.0421

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  36 in total

1.  Endogenous angiogenesis inhibitor blocks tumor growth via direct and indirect effects on tumor microenvironment.

Authors:  Dimitra Bourboulia; Sandra Jensen-Taubman; Matthew R Rittler; Hui Ying Han; Tania Chatterjee; Beiyang Wei; William G Stetler-Stevenson
Journal:  Am J Pathol       Date:  2011-09-18       Impact factor: 4.307

Review 2.  Placental membrane-type metalloproteinases (MT-MMPs): Key players in pregnancy.

Authors:  Alejandro Majali-Martinez; Ursula Hiden; Nassim Ghaffari-Tabrizi-Wizsy; Uwe Lang; Gernot Desoye; Martina Dieber-Rotheneder
Journal:  Cell Adh Migr       Date:  2016-01-08       Impact factor: 3.405

3.  Tissue inhibitor of metalloproteinase 2 inhibits activation of the β-catenin signaling in melanoma cells.

Authors:  Yuxuan Xia; Shaoping Wu
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 4.  Probing cellular microenvironments and tissue remodeling by atomic force microscopy.

Authors:  Thomas Ludwig; Robert Kirmse; Kate Poole; Ulrich S Schwarz
Journal:  Pflugers Arch       Date:  2007-12-06       Impact factor: 3.657

5.  SMYD5 Controls Heterochromatin and Chromosome Integrity during Embryonic Stem Cell Differentiation.

Authors:  Benjamin L Kidder; Runsheng He; Darawalee Wangsa; Hesed M Padilla-Nash; M Margarida Bernardo; Shijie Sheng; Thomas Ried; Keji Zhao
Journal:  Cancer Res       Date:  2017-09-26       Impact factor: 12.701

6.  Posttranslational regulation of membrane type 1-matrix metalloproteinase (MT1-MMP) in mouse PTEN null prostate cancer cells: Enhanced surface expression and differential O-glycosylation of MT1-MMP.

Authors:  Seaho Kim; Wei Huang; Emilio P Mottillo; Anjum Sohail; Yoon-Ah Ham; M Katie Conley-Lacomb; Chong Jai Kim; Guri Tzivion; Hyeong-Reh Choi Kim; Shihua Wang; Yong Q Chen; Rafael Fridman
Journal:  Biochim Biophys Acta       Date:  2010-07-08

7.  Tissue inhibitor of metalloproteinase-2 regulates matrix metalloproteinase-2-mediated endothelial barrier dysfunction and breast cancer cell transmigration through lung microvascular endothelial cells.

Authors:  Qiang Shen; Eugene S Lee; Robert L Pitts; Mack H Wu; Sarah Y Yuan
Journal:  Mol Cancer Res       Date:  2010-06-22       Impact factor: 5.852

Review 8.  MT4-(MMP17) and MT6-MMP (MMP25), A unique set of membrane-anchored matrix metalloproteinases: properties and expression in cancer.

Authors:  Anjum Sohail; Qing Sun; Huiren Zhao; M Margarida Bernardo; Jin-Ah Cho; Rafael Fridman
Journal:  Cancer Metastasis Rev       Date:  2008-06       Impact factor: 9.264

9.  New Strategies for the Next Generation of Matrix-Metalloproteinase Inhibitors: Selectively Targeting Membrane-Anchored MMPs with Therapeutic Antibodies.

Authors:  Laetitia Devy; Daniel T Dransfield
Journal:  Biochem Res Int       Date:  2010-10-28

Review 10.  miRNAs regulate expression and function of extracellular matrix molecules.

Authors:  Zina Jeyapalan Rutnam; Thomas N Wight; Burton B Yang
Journal:  Matrix Biol       Date:  2012-11-15       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.